vadimezan has been researched along with Cancer of Ovary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbera, M; Brindle, KM; Caputo, A; Carrara, M; Gobbi, S; Hu, DE; Kettunen, MI | 1 |
| Barbera, M; Bisi, A; Caputo, A; Carrara, M; Gobbi, S; Rampa, A; Zampiron, A | 1 |
| Baguley, BC; Cao, Z; Ching, LM; Joseph, WR; Marshall, ES; Mountjoy, KG | 1 |
| Baguley, BC; Cao, Z; Ching, LM; Jameson, MB; Kieda, C; Zwain, S | 1 |
1 trial(s) available for vadimezan and Cancer of Ovary
| Article | Year |
|---|---|
Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acid.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Blotting, Northern; Breast Neoplasms; Cells, Cultured; Chemokine CXCL10; Chemokines, CXC; Colonic Neoplasms; Endothelium, Vascular; Female; Humans; Interferons; Mice; Mice, Inbred C57BL; Ovarian Neoplasms; RNA, Messenger; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 2002 |
3 other study(ies) available for vadimezan and Cancer of Ovary
| Article | Year |
|---|---|
Immune-modulating and anti-vascular activities of two xanthenone acetic acid analogues: A comparative study to DMXAA.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Female; Flow Cytometry; Humans; I-kappa B Kinase; Immunity, Cellular; Leukemia; Magnetic Resonance Imaging; Mice; Mice, Inbred CBA; Microcirculation; NF-kappa B; Ovarian Neoplasms; Phosphorylation; Sarcoma, Experimental; Tumor Necrosis Factor-alpha; Umbilical Veins; Xanthones | 2009 |
The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Female; Flavonoids; Humans; Lipopolysaccharides; Monocytes; Nitric Oxide; Ovarian Neoplasms; Tumor Necrosis Factor-alpha; Xanthones | 2008 |
Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Lipopolysaccharides; Liver; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; RNA, Messenger; Spleen; Stimulation, Chemical; Transplantation, Heterologous; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 1999 |